| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $256.8M | +59.6% |
| Cost of Revenue | $227.5M | +50.4% |
| Gross Profit | $29.4M | +202.3% |
| R&D Expense | $11.6M | +103.5% |
| SG&A Expense | $141.1M | -1.3% |
| Operating Income | -$131.6M | +14.2% |
| Pre-tax Income | -$129.0M | +4.8% |
| Income Tax | -$2.3M | -5538.1% |
| Net Income | -$44.3M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $117.3M | -43.8% |
| Accounts Receivable | $45.8M | +31.4% |
| Current Assets | $205.4M | -23.2% |
| Total Assets | $803.8M | -0.4% |
| Current Liabilities | $111.4M | +24.7% |
| Total Liabilities | $360.0M | +35.2% |
| Stockholders' Equity | -$256.1M | -59.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.3M | +80.4% |
| Capital Expenditures | $94.8M | -40.3% |
| Investing Cash Flow | -$94.5M | +34.1% |
| Financing Cash Flow | $13.1M | -90.8% |
| Free Cash Flow | -$102.0M | +47.9% |
| -4.5% |
| EPS (Basic) | -$0.41 | +10.9% |
| EPS (Diluted) | -$0.41 | +10.9% |